Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy
Cancer, a group of diseases responsible for the second largest cause of global death, is considered one of the main public health problems today. Despite the advances, there are still difficulties in the development of more efficient cancer therapies and fewer adverse effects for the patients. In th...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/8/1167 |
| _version_ | 1797522436250402816 |
|---|---|
| author | Giovanna C. N. B. Lôbo Karen L. R. Paiva Ana Luísa G. Silva Marina M. Simões Marina A. Radicchi Sônia N. Báo |
| author_facet | Giovanna C. N. B. Lôbo Karen L. R. Paiva Ana Luísa G. Silva Marina M. Simões Marina A. Radicchi Sônia N. Báo |
| author_sort | Giovanna C. N. B. Lôbo |
| collection | DOAJ |
| description | Cancer, a group of diseases responsible for the second largest cause of global death, is considered one of the main public health problems today. Despite the advances, there are still difficulties in the development of more efficient cancer therapies and fewer adverse effects for the patients. In this context, nanobiotechnology, a materials science on a nanometric scale specified for biology, has been developing and acquiring prominence for the synthesis of nanocarriers that provide a wide surface area in relation to volume, better drug delivery, and a maximization of therapeutic efficiency. Among these carriers, the ones that stand out are those focused on the activation of the immune system. The literature demonstrates the importance of this system for anticancer therapy, given that the best treatment for this disease also activates the immune system to recognize, track, and destroy all remaining tumor cells. |
| first_indexed | 2024-03-10T08:29:21Z |
| format | Article |
| id | doaj.art-7d1ed598d626426daed0459dcf3e4384 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T08:29:21Z |
| publishDate | 2021-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-7d1ed598d626426daed0459dcf3e43842023-11-22T09:13:38ZengMDPI AGPharmaceutics1999-49232021-07-01138116710.3390/pharmaceutics13081167Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer TherapyGiovanna C. N. B. Lôbo0Karen L. R. Paiva1Ana Luísa G. Silva2Marina M. Simões3Marina A. Radicchi4Sônia N. Báo5Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilDepartment of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilDepartment of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilDepartment of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilDepartment of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilDepartment of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, BrazilCancer, a group of diseases responsible for the second largest cause of global death, is considered one of the main public health problems today. Despite the advances, there are still difficulties in the development of more efficient cancer therapies and fewer adverse effects for the patients. In this context, nanobiotechnology, a materials science on a nanometric scale specified for biology, has been developing and acquiring prominence for the synthesis of nanocarriers that provide a wide surface area in relation to volume, better drug delivery, and a maximization of therapeutic efficiency. Among these carriers, the ones that stand out are those focused on the activation of the immune system. The literature demonstrates the importance of this system for anticancer therapy, given that the best treatment for this disease also activates the immune system to recognize, track, and destroy all remaining tumor cells.https://www.mdpi.com/1999-4923/13/8/1167nanocarriersimmune systemnanobiotechnologycancer |
| spellingShingle | Giovanna C. N. B. Lôbo Karen L. R. Paiva Ana Luísa G. Silva Marina M. Simões Marina A. Radicchi Sônia N. Báo Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy Pharmaceutics nanocarriers immune system nanobiotechnology cancer |
| title | Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy |
| title_full | Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy |
| title_fullStr | Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy |
| title_full_unstemmed | Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy |
| title_short | Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy |
| title_sort | nanocarriers used in drug delivery to enhance immune system in cancer therapy |
| topic | nanocarriers immune system nanobiotechnology cancer |
| url | https://www.mdpi.com/1999-4923/13/8/1167 |
| work_keys_str_mv | AT giovannacnblobo nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy AT karenlrpaiva nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy AT analuisagsilva nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy AT marinamsimoes nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy AT marinaaradicchi nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy AT sonianbao nanocarriersusedindrugdeliverytoenhanceimmunesystemincancertherapy |